Skip to main content
. Author manuscript; available in PMC: 2018 Nov 5.
Published in final edited form as: J Nerv Ment Dis. 2010 Aug;198(8):597–600. doi: 10.1097/NMD.0b013e3181ea4d3d

Table 1.

Generalized Estimating Equations determine preliminary IPT-P pilot outcomes

Dependent Variable Baseline Mean (SD) 12-weeks Mean (SD) 24-weeks Mean (SD) 36-weeks Mean (SD)


(n = 17) (n = 12) (n = 11) (n = 9) % change z p effect size
HRSD-17 20.2 (4.9) 11.8 (5.3) 15.3 (5.9) 11.6 (6.0) 42.7 −4.43 <.001 1.57
BDI 29.0 (8.0) 25.0 (7.0) 22.0 (7.0) 19.6 (11.4) 32.6 −4.11 <.001 .96
SAS-SR 2.7 (0.4) 2.4 (1.2) 2.8 (0.5) 2.3 (0.6) 14.8 −2.12 .03 .77
MPI Pain Interference 4.4 (1.4) 4.3 (1.3) 4.7 (1.0) 4.3 (1.3) 2.3 −1.07 .28 .13

Notes. BDI: Beck Depression Inventory; HRSD-17: Hamilton Rating Scale for Depression – 17 items; SAS-SR: Social Adjustment Scale - Self-Report; MPI:Multidimensional Pain Inventory; analyses controlled for baseline antidepressant medication use; pain and social adjustment analyses also controlled for baseline HRSD-17.

HHS Vulnerability Disclosure